Cita APA

Viscusi, E. R., Skobieranda, F., Soergel, D. G., Cook, E., Burt, D. A., & Singla, N. (2019). APOLLO-1: A randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy. J Pain Res.

Chicago Style Citation

Viscusi, Eugene R., Franck Skobieranda, David G. Soergel, Emily Cook, David A. Burt, i Neil Singla. "APOLLO-1: A Randomized Placebo and Active-controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-biased Ligand At the µ-opioid Receptor, for Management of Moderate-to-severe Acute Pain Following Bunionectomy." J Pain Res 2019.

Cita MLA

Viscusi, Eugene R., et al. "APOLLO-1: A Randomized Placebo and Active-controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-biased Ligand At the µ-opioid Receptor, for Management of Moderate-to-severe Acute Pain Following Bunionectomy." J Pain Res 2019.